Amrita University launch wearable device for home monitoring of glucose and BP

By
0
181

– Patients can use the wearable, non-invasive device to measure six body parameters including blood glucose, blood pressure, heart rate, blood oxygen, respiratory rate and 6-lead ECG, from the comfort of their home

– The device, connected to the smart phone, can serve as a micro-bedside monitor in rural clinics

KOCHI, India, March 2, 2022 /PRNewswire/ — Amrita University has developed a device for home-monitoring of glucose and blood pressure. Amrita Spandanam, as the device is called, will be sold online and through pharmacists across the country.

Amrita University Campus
Amrita University Campus

Developed and patented by the varsity’s Centre for Wireless Networks and Applications, it is a wearable, six-in-one device that is an excellent replacement for a bedside monitor. It can be used to measure six body parameters including blood glucose, blood pressure, heart rate, blood oxygen, respiratory rate, and 6-lead ECG.

Said Dr Maneesha V Ramesh, the Provost of Amrita University who led the team of researchers: “Amrita Spandanam is a revolutionary device that has bagged several US patents, with results published in top scientific journals. It offers a quick, easy, affordable and non-invasive way to monitor and detect diabetes, cardiovascular diseases, hypertension, sleep apnea and allergy attacks from the comfort of one’s home. The product was extensively tested on 1000 patients at Amrita Hospital in Kochi and various remote clinics in Kerala. Last year, these devices were successfully deployed at Amrita Hospital to remotely monitor the progression of severity in COVID-19 patients.”

Amrita Spandanam is connected to the patient’s smartphone. The data is sent to a secure hospital cloud which enables any doctor authorized by the patient to access the vital parameters remotely from any location. The product also integrates multiple -learning models that can predict the potential deterioration of patients’ health and provide early warning decision support to doctors for acute hypotensive episodes, sepsis, sleep apnea, and atrial fibrillation.

About Amrita University

http://www.amrita.edu

Amrita partners with academic, industry and governmental institutions across the world to accomplish human-centered, translational, and groundbreaking research. Some of Amrita’s partners include Harvard University, Columbia University, King’s College London, KTH – Royal Institute of Technology, VU Amsterdam, the British Geological Society, University of Oxford, Italian National Research Council, Deakin University, and the University of Tokyo. Sri Mata Amritanandamayi Devi (Amma), a world-renowned humanitarian leader is the founder, Chancellor, and guiding light of Amrita University.

Contact: Dr. Maneesha Ramesh, maneesha@amrita.edu

Spread the love and Earn Tokens

Comments